home · filing · 0001493152-21-016285
8-K
filed July 7, 2021, 7:59 PM ET
ticker FUNI
CIK 0001502966
leadership
confidence high
sentiment neutral
materiality 0.60
Digipath appoints Stone Douglass to board, Todd Denkin as President
Hypha Labs, Inc.
Stone Douglass appointed to Board on July 1, 2021; received option for 1M shares at $0.06 exercise price.
Todd Denkin appointed President; previously consultant via TD Media (500K shares, $8k/month).
Denkin awarded 1.5M shares of common stock and $150k annual salary, replacing consulting arrangement.
Denkin previously served as CEO (2014-2016) and President (2014-2019); returns to management role.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Todd Denkin
President
Effective 2021-07-01
Filed July 7, 2021, 7:59 PM ET
On July 1, 2021, the Board appointed Todd Denkin to serve as the President of the Company.
Appointed
A. Stone Douglass
Board of Directors
Effective 2021-07-01
Filed July 7, 2021, 7:59 PM ET
On July 1, 2021, A. Stone Douglass, 73, was appointed to the Board of Directors (the “Board”) of Digipath, Inc. (the “Company”).
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Todd Denkin was appointed as President at Hypha Labs, Inc..
Action appointed
Role President
Exact text from the filing
On July 1, 2021, the Board appointed Todd Denkin to serve as the President of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
A. Stone Douglass was appointed as Board of Directors at Hypha Labs, Inc..
Action appointed
Role Board of Directors
Exact text from the filing
On July 1, 2021, A. Stone Douglass, 73, was appointed to the Board of Directors (the “Board”) of Digipath, Inc. (the “Company”).
View on SEC.gov
Source: SEC EDGAR
accession 0001493152-21-016285
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.